(21 days)
Not Found
No
The document describes a traditional medical device (femoral stem) and does not mention any AI or ML capabilities in its intended use, device description, or performance studies.
Yes
The device, a femoral stem component for total hip replacement, is intended to treat medical conditions like osteoarthritis, rheumatoid arthritis, and fractures, which directly addresses a disease or condition.
No
This device is a femoral stem component used in total hip replacement surgery, which is a treatment for various hip conditions, not a tool for diagnosing them.
No
The device description clearly states the device is a physical femoral stem component made from cast Cobalt Chromium Molybdenum alloy, intended for surgical implantation. It is not software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. They are used to provide information for diagnosis, monitoring, or screening.
- Device Description and Intended Use: The provided information clearly describes a surgical implant (a femoral stem component) used in total hip replacement surgery. It is a physical device implanted into the body to replace a damaged part of the hip joint.
- Lack of Diagnostic Testing: There is no mention of this device being used to analyze biological samples or provide diagnostic information. Its function is purely mechanical and structural within the body.
Therefore, based on the provided information, the AcuMatch L-Series Cemented Femoral Stem Component is a surgical implant, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
AcuMatch L-Series Cemented Femoral Stem Components are indicated for use in skeletally mature individuals undergoing primary surgery for total hip replacement due to osteoarthritis, rheumatoid arthritis, osteonecrosis, ankylosing spondylitis, congenital hip dysplasia, post-traumatic degenerative problems of the hip, and for treatment of proximal femoral fractures where prosthetic replacement is determined by the surgeon as the preferred treatment. Components of Exactech Hip Systems are also potentially indicated for revision of failed previous reconstructions where sufficient bone stock is present and to restore mobility resulting from previous fusion.
AcuMatch L-Series Cemented Femoral Stem Components are intended to be used with bone cement.
Product codes (comma separated list FDA assigned to the subject device)
JDI
Device Description
L-Series Femoral Stem Components are made from cast Cobalt Chromium Molybdenum alloy conforming to ASTM F 75-98. Mechanical properties for ultimate strength, ductility, and grain structure are controlled by this specification. The L-Series components have a satin finish and are intended for cemented applications only.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Hip
Indicated Patient Age Range
skeletally mature individuals
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Three-Point fatigue testing of the Exactech L-Series device places the strength of the stem in the range of other legally marketed devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3350 Hip joint metal/polymer semi-constrained cemented prosthesis.
(a)
Identification. A hip joint metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a hip joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and an acetabular resurfacing component made of ultra-high molecular weight polyethylene and is limited to those prostheses intended for use with bone cement (§ 888.3027).(b)
Classification. Class II.
0
Koo1335
510(k) Summary of Safety and Effectiveness
| Trade Name: | Exactech® AcuMatch L-Series
Cemented Femoral Stem Component |
|----------------------|------------------------------------------------------------------------------------|
| Common Name: | Femoral Stem |
| Classification Name: | Prosthesis, Hip, Semi-Constrained, Metal/Polymer,
Cemented, (Femoral Component) |
Legally Marketed Devices for Substantial Equivalence Comparison:
| Model | Manufacturer |
|---|---|
| AuRA | Exactech (#K961304) |
| Conquest FX | Smith & Nephew |
| Spectron | Smith & Nephew |
| PFC | Depuy |
Substantial Equivalence Information:
The Exactech AcuMatch L-Series Cemented Femoral component has similar indications and contraindications as other femoral components legally marketed in the United States. In addition the L-Series has similar technological features to other devices, most notably Exactech's AuRA femoral component. The L-Series originated from design modifications made to the Exactech's AuRA design (ref. #K961304). In addition, the proposed L-Series component is similar to femoral components currently marketed by other manufacturers. These include the "Conquest FX" and "Spectron" by Smith & Nephew and the "PFC" by Depuy. The Conquest FX model like the L-Series is manufactured from cast cobalt chrome. Other similarities between the predicate stems and the proposed L-Series design include a satin surface treatment and a proximal to distal taper. All of the components are supplied sterile. Three-Point fatigue testing of the Exactech L-Series device places the strength of the stem in the range of other legally marketed devices.
1
510(k) Summary of Safety and Effectiveness
Indications for Use:
AcuMatch L-Series Cemented Femoral Stem Components are indicated for use in skeletally mature individuals undergoing primary surgery for total hip replacement due to osteoarthritis, rheumatoid arthritis, osteonecrosis, ankylosing spondylitis, congenital hip dysplasia, post-traumatic degenerative problems of the hip, and for treatment of proximal femoral fractures where prosthetic replacement is determined by the surgeon as the preferred treatment. Components of Exactech Hip Systems are also potentially indicated for revision of failed previous reconstructions where sufficient bone stock is present and to restore mobility resulting from previous fusion.
AcuMatch L-Series Cemented Femoral Stem Components are intended to be used with bone cement.
Contraindications:
AcuMatch L-Series Cemented Femoral Stem Components are contraindicated in patients with active infection, patients without sufficient bone stock to allow appropriate insertion and fixation of the prosthesis, in neuromuscular disorders that do not allow control of the hip joint, and in patients whose weight, age, or activity level would cause the surgeon to expect early failure of the system.
Device Description:
L-Series Femoral Stem Components are made from cast Cobalt Chromium Molybdenum alloy conforming to ASTM F 75-98. Mechanical properties for ultimate strength, ductility, and grain structure are controlled by this specification. The L-Series components have a satin finish and are intended for cemented applications only.
Packaging. Labeling and Sterilization:
L-Series components are first packaged at Exactech in a certified Class 100,000 Cleanroom. The products are then shipped to an ISO/EN certified Irradiation Facility and returned to Exactech where they are quarantined pending a final product inspection. Qualifying implants are then released for distribution. Packaging materials are outlined in the following table.
2
510(k) Summary of Safety and Effectiveness
| Material | Composition |
|---|---|
| Inner / Outer Trays | PETG – 0.040" thickness |
| Tray Lids | Spun-Bonded Olefin - Tyvek® |
| Inserts | Medium grade LD45 Foam |
| Box | Heavy weight cardboard |
| Outer Shrink-Wrap | Clear, Light-Weight Plastic |
| Shipping Cartons | Heavy-weight Corrugated Cardboard |
Utilization and implantation instructions are included in the package insert provided with each product. The name, size, dimension, material, lot, serial number and sterility status are indicated on the labeling.
Sterilization Specifications:
Method: Gamma radiation (Cobalt 60 source) Dose: 25 – 37 kGy Sterility Assurance Level (SAL): 10-6
3
Image /page/3/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" written around it. Inside the circle is a stylized image of three human profiles facing to the right, with the profiles overlapping each other.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAY 1 8 2000
Ms. Lisa Simpson Regulatory Representative Exactech, Inc. 2320 N.W. 66th Court Gainesville, Florida 32653
Re: K001335
Trade Name: Exactech® AcuMatch™ Integrated Hip System L-series Cemented Femoral Stem Component Regulatory Class: II Product Code: JDI Dated: April 26, 2000 Received: April 27,2000
Dear Ms. Simpson:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general control provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
4
Page 2 - Ms. Lisa Simpson
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or at (301) 443-6597, or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Neil RPEyden
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number:
Kool335
Device Name:
Exactech® AcuMatch™ Integrated Hip System L-Series Cemented Femoral Stem Component
Indications for Use:
AcuMatch L-Series Cemented Femoral Stem Components are indicated for use in skeletally mature individuals undergoing primary surgery for total hip replacement due to SKeloary mature marriad arthritis, osteonecrosis, ankylosing spondylitis, congenital hip Osteourinitie, Includio degenerative problems of the hip, and for treatment of proximal as the fentoral fractures whice pponents of Exactech Hip Systems are also potentially indicated presenta a softailed previous reconstructions where sufficient bone stock is present and to restore mobility resulting from previous fusion.
AcuMatch L-Series Cemented Femoral Stem Components are intended to be used with bone cement.
Contraindications:
AcuMatch L-Series Cemented Femoral Stem Components are contraindicated in patients with active infection, patients without sufficient bone stock to allow appropriate insertion and fixation of the prosthesis, in neuromuscular disorders that do not allow control of the hip joint, and in patients whose weight, age, or activity level would cause the surgeon to expect early failure of the system.
Please do not write below this line - use another page if needed.
Concurrence of CDRH, Office of Device Evaluation (ODE)
| (Division Sign-Off) | NRO for cmw |
|---|---|
| Division of General Restorative Devices | |
| 510(k) Number | K001335 |
| Prescription Use | Yes | or | Over the Counter Use | No |
|---|---|---|---|---|
| ------------------ | ----- | ---- | ---------------------- | ---- |
Section 3 Page 1 of 1